It has been demonstrated that miR-29 family is the microglial modulators of the insulin-like growth factor-1 (IGF-1) and fractalkine ligand (CX3CL1) [129], supporting the hypothesis that impairment of IR and IGF-1 mediates cognitive impairment in AD [130]. Here, IGF1 is linked to Alzheimer disease.